You searched for "outcomes"
Endoscopic myringoplasty: a promising alternative to microscopic surgery
Endoscopes have revolutionised otitis media surgery in recent years and are increasingly used in the surgical management of cholesteatoma, sinus tympani pathology and facial nerve surgery. Despite this, the development of endoscopic myringoplasty and how this compares to its microscopic...
TIVA in FESS: a meta-analysis
This meta-analysis is from Rochester, New York, and aims to add more evidence for the use of TIVA in endoscopic sinus surgery (FESS) to arm rhinologists keen for a quick, bloodless FESS in the discussion with anaesthetists who prefer inhalation....
Quality of life after cochlear implantation in the older population
Cochlear implants (CI) have been increasingly adopted in older adults with severe to profound hearing loss as a result of the growing and ageing world population. There is much interest in the cost-effectiveness and quality of life in CI users....
Moving towards implanting children below 12 months of age
Newborn hearing screening has ensured that deaf infants are identified soon after birth so that habilitation can begin as early as possible. Cochlear implantation is a key component of early intervention for some children, but it is often not performed...
Systematic review and meta-analysis showing benefit of cochlear implantation in adults with single-sided deafness
This article presents results of a systematic review and meta-analysis to further investigate the impact of unilateral cochlear implantation (CI) in adults with single-sided deafness (SSD) with regards to speech perception in quiet and noise, tinnitus, sound localisation and quality...
COVID vaccination and its relation to Bell’s palsy
The SARS-CoV-2 virus outbreak in 2020 continues to be investigated as well as its after-effects on those infected by it. The vaccines created for the public were groundbreaking achievements, evidenced by the lives saved by them and the return to...Neuromod establishes global leadership team following launch of Lenire in Spain
Neuromod Devices has announced the formation of a global commercial leadership team to further commercialise its Lenire tinnitus treatment device through key partnerships.Lenire®, the tinnitus treatment device, now available in Norway
Neuromod Devices Ltd., has reached an agreement with HØR AS, Norway’s largest private provider of hearing and tinnitus care, to make its Lenire tinnitus treatment device available in Norway.
